MAIDENHEAD, BERKSHIRE – TUESDAY 24 JANUARY 2023 – With diabetes prevalence expected to reach almost 5.5 million across the UK by 2030ii, new results from a first-of-its-kind survey by Abbott has identified a clear disconnect between the perceptions of the British public and those living with diabetes when it comes to stigma surrounding the condition.
The survey of 1,500 people shows the UK population has a good understanding of the impact of managing the condition, accurately associating diabetes with “insulin” (76%), and “testing sugar levels” (40%)i. However, 80% of the general public claim to have never witnessed diabetes stigma, despite almost the same proportion of the diabetes community (73%) having seen stigmatising behaviour towards the condition, particularly on social media, TV and onlinei.
The disconnect between the stigma experienced by people with diabetes and the general public’s lack of awareness of it, suggests widespread unconscious bias towards those with diabetes, which can lead to negative effects on emotional wellbeing and health outcomes.iii,ivRoughly one in four (24%) people with diabetes surveyed agree that others’ opinions have affected their ability to manage their conditioni.
Stigma is created by a lack of knowledge and a fear of the unknown. When people see something they don’t understand or perceive as scary, they can react negatively. For people with diabetes this can play out in many ways such as food judgement, social or workplace exclusion, or inadvertently making hurtful comments. Something as simple as ‘should you be eating that?’ can lead to feelings of blame and judgementii,iii.
Professor Deborah Christie, consultant clinical psychologist and clinical lead for paediatric and adolescent psychological services at University College London Hospital’s NHS Foundation Trust said, "Abbott has uncovered important findings about the role that unconscious bias plays in diabetes stigma and the negative impact that this can have. Stigma experienced by people with diabetes is one of the largest barriers to them engaging with care and treatment. If you feel blamed or judged in any part of your life, then it can have a significant effect on your emotional wellbeing, and you will be less likely to engage with that area."
Abbott’s survey highlights further insights for those living with diabetes, including:
Abbott has launched a new campaign in the UK, Let’s Change Perspective to explore the impact of unconscious bias and to help change the conversation around diabetes. This includes a new tool, the Let’s Change Perspective Guide, developed in partnership with people with diabetes and Professor Christie, with input and guidance from Diabetes UK. The tool aims to empower everyone to challenge diabetes stigma in the moment in various situations such as in work, or hearing a joke or hurtful comment about diabetes. Allyship is key in helping to reduce stigma and improve the lives of people with diabetes.
Douglas Twenefour, Head of Care at Diabetes UK, said: “We welcome the Let’s Change Perspective campaign and guide as, together, they help demonstrate the importance of working collaboratively to address the stigma that affects people with diabetes. It’s incredibly important that people with diabetes are supported and empowered to live their lives and manage their condition as best they can, free from stigma.”
Professor Christie adds, "It is critical that the diabetes community and general public can come together with compassion and utilise tools, such as the Let’s Change Perspective Guide, to challenge bias and start to change the conversation."
Despite the public’s misconceptions of diabetes, the survey also found positive signals for improvement as the public recognise the impact of stigma, with approximately half (47%) agreeing that the language used to speak about diabetes reinforces stigmai and three quarters (75%) agreeing more education is needed to understand more about the conditioni.
Neil Harris, general manager of Abbott's diabetes care business in the UK and Ireland, commented: "We want all people with diabetes to feel confident to care for themselves and to seek the right support for themselves and their condition. If we all took the time to understand diabetes a little better, and challenge the stereotypes that inadvertently cause harm, we can make a big difference to the lives of people living with this complex condition."
Through the Let’s Change Perspective campaign, Abbott will continue to work with the diabetes community to raise awareness of the impact of diabetes stigma and provide helpful solutions to reduce unconscious bias and support people with diabetes. __________________________________________________________________
Notes
Case studies available upon request.
The survey was commissioned by Abbott and conducted by Opinion Health in August 2022. The study had 1,500 participants from the UK, including 500 people with diabetes and 1,000 members of general public.
Let’s Change Perspective Guide was developed in partnership with people with diabetes and Professor Deborah Christie, with input and guidance from Diabetes UK. The guide looks at situations where stigma is frequently experienced and aims to arm people with diabetes, and importantly the general public, to challenge bias in the moment.
Tips from the guide include:
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritional and branded generic medicines. Our 113,000 colleagues serve people in more than 160 countries.
Abbott has the world’s most widely used sensor-based glucose monitorvi. The FreeStyle Libre system, which has already changed the lives of approximately 4.5 million people across more than 60 countriesvii by providing breakthrough technology that is accessible and affordableviii.
Connect with us at www.abbott.co.uk, on LinkedIn at www.linkedin.com/company/abbott-/, on Facebook at www.facebook.com/Abbott and on Twitter @AbbottNews.
References
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimized for your specific screen size.
FOLLOW ABBOTT